Tuberous sclerosis gene products in proliferation control
Authors:
- Markus HengstschlägerMarkus Hengstschläger
- David M RodmanDRDavid M Rodman
- Angelina MilolozaAMAngelina Miloloza
- Elke Hengstschläger-OttnadEHElke Hengstschläger-Ottnad
- Margit RosnerMRMargit Rosner
- Marion KubistaMKMarion Kubista
- 1 July 2001
- journal article
- review article
- Published by Elsevier in Mutation Research - Reviews in Mutation Research
- Vol. 488 (3) , 233-239
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Molecular genetic advances in tuberous sclerosisHuman Genetics, 2000
- Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and developmentProceedings of the National Academy of Sciences, 1998
- The genetic basis of tuberous sclerosisMolecular Medicine Today, 1998
- Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34Science, 1997
- Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.Proceedings of the National Academy of Sciences, 1996
- Suppression of the Neoplastic Phenotype by Replacement of theTsc2Gene in Eker Rat Renal Carcinoma CellsBiochemical and Biophysical Research Communications, 1996
- A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancerNature Genetics, 1995
- Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.Proceedings of the National Academy of Sciences, 1994
- Identification and characterization of the tuberous sclerosis gene on chromosome 16Cell, 1993
- Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer.Proceedings of the National Academy of Sciences, 1993